{"name":"Edgar LeClaire, MD","slug":"edgar-leclaire-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Active B&O suppository of belladonna","genericName":"Active B&O suppository of belladonna","slug":"active-b-o-suppository-of-belladonna","indication":"Abdominal cramping and spasms","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Onabotulinumtoxin A (BoNT)","genericName":"Onabotulinumtoxin A (BoNT)","slug":"onabotulinumtoxin-a-bont","indication":"Cervical dystonia","status":"marketed"}]}],"pipeline":[{"name":"Active B&O suppository of belladonna","genericName":"Active B&O suppository of belladonna","slug":"active-b-o-suppository-of-belladonna","phase":"marketed","mechanism":"Belladonna alkaloids block muscarinic acetylcholine receptors to reduce smooth muscle contractions and secretions in the gastrointestinal and urinary tracts.","indications":["Abdominal cramping and spasms","Irritable bowel syndrome symptoms"],"catalyst":""},{"name":"Onabotulinumtoxin A (BoNT)","genericName":"Onabotulinumtoxin A (BoNT)","slug":"onabotulinumtoxin-a-bont","phase":"marketed","mechanism":"Onabotulinumtoxin A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","indications":["Cervical dystonia","Blepharospasm","Strabismus","Chronic migraine","Overactive bladder"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}